Main menu button

Analysis Alligator: Promising results from partner

21 May 2019

Alligator’s partner for the ADC-1013-project has revealed long-awaited trial results. Strong early efficacy results for the CD40-class of immuno-oncology drugs in pancreatic cancer have also emerged recently, underlining opportunites. Increased clinical activity could generate value-driving news flow.

Read the full report (Swedish) here.

Analysis Alligator: Promising results from partner